ORCID

0009-0000-8820-2050 (Valle), 0000-0001-5947-4778 (Yehya)

Document Type

Article

Publication Date

2025

DOI

10.1016/j.jaccas.2025.104448

Publication Title

JACC: Case Reports

Volume

30

Issue

19

Pages

104448 (1-4)

Abstract

Background

Transcatheter tricuspid edge-to-edge repair (T-TEER) is an emerging technology used to treat severe tricuspid regurgitation (TR). The pivotal trials demonstrating the safety and efficacy of T-TEER exclude patients with severely reduced left ventricular function (≤20%).

Case Summary

We demonstrate the use of T-TEER in a patient with end-stage hypertrophic cardiomyopathy who suffered acute, torrential TR and subsequently developed cardiogenic shock as a complication of high-risk transvenous lead extraction. Why Beyond the Guidelines Currently, there are no guidelines addressing the nonsurgical emergent management of acute TR.

Discussion

The TriClip system (Abbott) may have certain advantages when used in managing acute primary TR compared with other valve repair and/or replacement approaches.

Take-Home Message

TriClip can be considered for urgent use to correct severe TR in hemodynamically unstable patients who are not surgical candidates.

Rights

© 2025 The Authors.

Published under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License.

Original Publication Citation

Valle, N. J., Yehya, A., Rathore, A., Kiehl, E. L., & Summers, M. R. (2025). Emergent transcatheter tricuspid edge-to-edge repair for right ventricular shock from tricuspid regurgitation in hypertrophic cardiomyopathy. JACC: Case Reports, 30(19), 1-4, Article 104448. https://doi.org/10.1016/j.jaccas.2025.104448

Additional Files
ScienceDirect_files_04Aug2025_14-21-06.795.zip (17091 kB)
Download all supplementary files included with this article
Download

Share

COinS